---
title: AsPC-1-fluc Orthotopic Model - TD2 Precision Oncology
description: AsPC-1-fluc is a luminescent pancreatic cancer cell line used for studying tumor behavior and testing therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/aspc-1-fluc.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# AsPC-1-fluc Orthotopic Model
**Synonyms:** -
AsPC-1-fluc is a luminescent pancreatic cancer cell line derived from AsPC-1. It expresses luciferase, enabling non-invasive monitoring of tumor growth and response to treatments using bioluminescence imaging techniques. AsPC-1-fluc serves as a valuable tool for preclinical research in pancreatic cancer, allowing researchers to study tumor behavior, evaluate drug efficacy, and explore therapeutic approaches. This cell line offers a practical platform for investigating pancreatic cancer biology and developing novel treatment strategies.
## Model Details
**Cancer Type:** Pancreatic Cancer
**Model Name:** AsPC-1-fluc
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** N/A
## AsPC-1-fluc Growth curves
Growth of AsPC-1-fluc after orthotopic intrapancreatic injection of Nu/Nu mice (n=10)
### Request Additional Syngeneic Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)